GAM
Groupama Asset Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,198
| Closed | -$497K | – | 390 |
|
|
2025
Q1 | $497K | Sell |
3,198
-218
| -6% | -$33.9K | 0.01% | 341 |
|
|
2024
Q4 | $627K | Buy |
3,416
+2,079
| +155% | +$381K | 0.01% | 318 |
|
|
2024
Q3 | $211K | Buy |
1,337
+24
| +2% | +$3.8K | 0.01% | 396 |
|
|
2024
Q2 | $271K | Buy |
1,313
+553
| +73% | +$114K | ﹤0.01% | 402 |
|
|
2024
Q1 | $396K | Sell |
760
-1,162
| -60% | -$606K | 0.01% | 402 |
|
|
2023
Q4 | $455K | Buy |
+1,922
| New | +$455K | 0.01% | 345 |
|